NCT04030000View on ClinicalTrials.gov

Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 20, 2020

Primary Completion Date

August 30, 2022

Study Completion Date

January 30, 2023

Conditions
Uterine Carcinoma
Interventions
DRUG

Paclitaxel/Carboplatin

IV paclitaxel in combination with IP carboplatin

RADIATION

Pelvic radiation therapy

EBRT and vaginal brachytherapy

Trial Locations (1)

11040

Arisa Kapedani, New Hyde Park

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
lead

Northwell Health

OTHER